Millar also noted that Wegovy has been shown to reduce the risk of events such as stroke, heart attack or cardiovascular death in those who also have known heart disease
Individual factors such as adherence to lifestyle modifications, dietary compliance, physical activity levels, underlying medical conditions, genetics, and initial body weight all play important roles in determining your overall response to treatment
While GLP-1 agonists have been on the market for a few years now, longitudinal studies are needed on large groups of individuals for any conclusive findings
Neuroscience 153 , 634644 (2008)
Insurance Coverage: Whats Typically Allowed Most health plans limit coverage of Ozempic and the other GLP-1 medications to FDA-approved indicationsprimarily type 2 diabetes and, in some cases, chronic weight management
Sobos article on GLP-1 weight loss and muscle loss explains why the quality of weight loss matters as much as the number of pounds lost